Table 4.
Purpose of Internet of Things (IoT) or app use for health promotion or prevention or to improve symptoms or illnesses for Japanese working women.
Purpose of IoT or app use | Total sample (n=10,000), n (%) | Experience with health-related IoT or app use | ||||
|
|
Current use (n=1455), n (%) | Past use (n=695), n (%) | P value | ||
Health promotion or prevention | ||||||
|
Menstrual symptoms or disorders | 534 (5.3) | 375 (25.8) | 159 (22.9) | .16 | |
|
Premenstrual syndrome | 302 (3) | 211 (14.5) | 91 (13.1) | .42 | |
|
Infertility | 80 (0.8) | 49 (3.4) | 31 (4.5) | .26 | |
|
Pregnancy or childbirth-related symptoms or illnesses | 159 (1.6) | 95 (6.5) | 64 (9.2) | .03 | |
|
Menopausal symptoms | 180 (1.8) | 122 (8.4) | 58 (8.3) | ≥.99 | |
|
Postmenopausal hormone-related issues | 85 (0.9) | 59 (4.1) | 26 (3.7) | .82 | |
|
Mental disorder | 223 (2.2) | 153 (10.5) | 70 (10.1) | .81 | |
|
Insomnia | 285 (2.9) | 203 (14) | 82 (11.8) | .19 | |
|
Headaches or migraines | 213 (2.1) | 142 (9.8) | 71 (10.2) | .80 | |
|
Blood flow disorders | 144 (1.4) | 103 (7.1) | 41 (5.9) | .35 | |
|
Anemia | 110 (1.1) | 68 (4.7) | 42 (6) | .21 | |
|
Gastrointestinal disorders | 211 (2.1) | 146 (10) | 65 (9.4) | .68 | |
|
Nutritional disordersa | 620 (6.2) | 460 (31.6) | 160 (23) | <.001 | |
|
Female-specific cancerb | 148 (1.5) | 89 (6.1) | 59 (8.5) | .052 | |
|
Endometriosis and benign female-specific tumors | 62 (0.6) | 44 (3) | 18 (2.6) | .67 | |
|
Thyroid disorders | 38 (0.4) | 27 (1.9) | 11 (1.6) | .78 | |
|
Pelvic floor symptoms or diseases | 54 (0.5) | 32 (2.2) | 22 (3.2) | .23 | |
|
Others | 145 (1.5) | 122 (8.4) | 23 (3.3) | <.001 | |
Improve symptoms or illnesses | ||||||
|
Menstrual symptoms or disorders | 347 (3.5) | 249 (17.1) | 98 (14.1) | .09 | |
|
Premenstrual syndrome | 239 (2.4) | 173 (11.9) | 66 (9.5) | .12 | |
|
Infertility | 59 (0.6) | 37 (2.5) | 22 (3.2) | .49 | |
|
Pregnancy or childbirth-related symptoms or illnesses | 71 (0.7) | 42 (2.9) | 29 (4.2) | .15 | |
|
Menopausal symptoms | 140 (1.4) | 98 (6.7) | 42 (6) | .61 | |
|
Postmenopausal hormone-related issues | 90 (0.9) | 61 (4.2) | 29 (4.2) | ≥.99 | |
|
Mental disorder | 202 (2) | 142 (9.8) | 60 (8.6) | .45 | |
|
Insomnia | 247 (2.5) | 161 (11.1) | 86 (12.4) | .41 | |
|
Headaches or migraines | 236 (2.4) | 164 (11.3) | 72 (10.4) | .58 | |
|
Blood flow disorders | 168 (1.7) | 121 (8.3) | 47 (6.8) | .24 | |
|
Anemia | 130 (1.3) | 79 (5.4) | 51 (7.3) | .10 | |
|
Gastrointestinal disorders | 201 (2) | 135 (9.3) | 66 (9.5) | .93 | |
|
Nutritional disordersa | 563 (5.6) | 405 (27.8) | 158 (22.7) | .01 | |
|
Female-specific cancerb | 53 (0.5) | 36 (2.5) | 17 (2.4) | ≥.99 | |
|
Endometriosis and benign female-specific tumors | 63 (0.6) | 41 (2.8) | 22 (3.2) | .76 | |
|
Thyroid disorders | 51 (0.5) | 31 (2.1) | 20 (2.9) | .36 | |
|
Pelvic floor symptoms or diseases | 77 (0.8) | 43 (3) | 34 (4.9) | .03 | |
|
Others | 83 (0.8) | 69 (4.7) | 14 (2) | .003 |
aUnderweight, obesity, swelling, diet or nutritional disorders.
bCervical, uterine, ovarian, or breast cancer.